News coverage about Kewaunee Scientific (NASDAQ:KEQU) has trended positive on Tuesday, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Kewaunee Scientific earned a coverage optimism score of 0.26 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 44.2957090191611 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Kewaunee Scientific (NASDAQ KEQU) traded up $0.90 during midday trading on Tuesday, hitting $29.95. 100 shares of the company were exchanged, compared to its average volume of 1,878. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.12 and a quick ratio of 1.58. Kewaunee Scientific has a twelve month low of $20.95 and a twelve month high of $31.20. The company has a market cap of $81.48, a P/E ratio of 17.93 and a beta of 0.07.
Kewaunee Scientific (NASDAQ:KEQU) last released its earnings results on Tuesday, December 5th. The technology company reported $0.62 EPS for the quarter. Kewaunee Scientific had a net margin of 3.28% and a return on equity of 10.61%. The business had revenue of $41.47 million for the quarter.
In other Kewaunee Scientific news, Director Donald F. Shaw bought 2,000 shares of the firm’s stock in a transaction on Wednesday, December 27th. The stock was bought at an average cost of $28.79 per share, with a total value of $57,580.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Donald F. Shaw bought 888 shares of the firm’s stock in a transaction on Wednesday, December 26th. The stock was acquired at an average cost of $28.78 per share, with a total value of $25,556.64. Following the completion of the transaction, the director now directly owns 21,250 shares of the company’s stock, valued at $611,575. The disclosure for this purchase can be found here. Insiders own 20.20% of the company’s stock.
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.